Yusheng Liu | Interventional Cardiology | Best Researcher Award 

Posted on by Cardiology and Cardiovascular Medicine

Prof. Yusheng Liu | Interventional Cardiology | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile:

Scopus

🩺 PROF. YUSHENG LIU – A PIONEER IN HEART FAILURE & ECHOCARDIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

Prof. Yusheng Liu began his illustrious academic journey in Clinical Medicine at Taishan Medical School (now The First Medical University of Shandong), earning his Bachelor’s degree (1995–2000). His quest for deeper knowledge led him to pursue a Master’s degree in Internal Medicine with a focus on Cardiovascular Disease at Shandong University School of Medicine (2004–2007), followed by an M.D. in Cardiovascular Medicine (2010–2013) from the same institution.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since July 2000, Prof. Liu has served at the Second Hospital of Shandong University, currently holding the title of Deputy Chief Physician of Cardiovascular Medicine, Associate Professor, and Doctoral Supervisor. He also leads the Cardiac Care Unit (CCU) and plays a pivotal role in guiding the next generation of clinicians as a Master’s tutor.

His career also extends into professional societies, where he holds several leadership roles, including:

  • Executive Director, China Ultrasonic Medical Engineering Society (Echocardiography Division)

  • Vice Chairman, Shandong Ultrasound in Medicine Engineering Institute

  • Youth Leader, Shandong Medical Health System

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON INTERVENTIONAL CARDIOLOGY

Prof. Liu has dedicated his research to heart failure, echocardiography, coronary artery disease, and atherosclerosis. He has:

  • Led or contributed to multiple National Key Projects such as 973, 863, and the National Natural Science Foundation

  • Chaired international collaborations like the Macau SAR Science & Technology Fund

  • Focused heavily on biomarker-based diagnostics, ventricular function in diabetes, and plaque stability in coronary syndromes

His projects have bridged clinical and basic science, contributing to real-world patient improvements and high-impact academic knowledge.

🏆 IMPACT AND INFLUENCE

Prof. Liu’s work has been nationally and internationally recognized:

  • Two-time winner of National Science and Technology Progress Award

  • Recipient of multiple provincial awards including 4 second-place and 6 third-place Science & Tech Awards

  • Frequent keynote speaker at conferences such as:

    • 24th Great Wall International Cardiology Conference

    • 12th National Echo Cardiac Conference

    • 2016 Pharmacology & Ethnopharmacology Conference, Chicago, USA

He is also involved in clinical ethics, oncology cardiology, heart rehabilitation, and hypertension professional committees.

📚 ACADEMIC CITATIONS AND MEMBERSHIPS

Prof. Liu is a proud member of:

  • American Society of Echocardiography (ASE)

  • China Ultrasound Medical Engineering Society (Permanent Member)

  • Various Shandong Medical Associations across cardiology, ethics, and disaster medicine

His publications and research are cited in numerous national and international cardiovascular journals and conferences, further amplifying his impact on the global stage.

🧪 SCIENTIFIC PROJECTS (SELECTED)

Some of the noteworthy research projects under his leadership include:

  1. Huatong-Guokang Medical Scientific Research Project – Ministry of Education (2023)

  2. Clinical Elite Scientist Programme (2018)

  3. National Key R&D Plan (2022YFC3502100)

  4. Lipoprotein-Associated Phospholipase A2 and Plaque Stability (2014)

  5. JNK Pathway and Atherosclerosis Mechanism (2013)

  6. DPP-4 Inhibitors and Ventricular Function in Diabetic Patients (2013)

🏅 AWARDS AND HONORS

Prof. Liu has received:

  • Lecture Honorary Certificate – Pharmacology & Ethnopharmacology 2016

  • Shandong Soft Science Excellence Award

  • Outstanding Teaching Certificate – Weifang University (2016)

  • Advanced Medical Worker Honor – Phoenix Media

  • Scholarships from Shandong University and affiliated hospitals

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yusheng Liu stands as a leading voice in the evolution of cardiovascular care in China and beyond. His multidisciplinary influence spans clinical excellence, scientific innovation, academic mentorship, and global collaboration.

In the years to come, his focus on integrating precision medicine, biomarkers, and advanced imaging will continue shaping the future of heart failure diagnostics, ultrasound cardiology, and clinical translational research. With a legacy rooted in innovation and education, he continues to inspire and uplift the cardiovascular medicine community.

📑 NOTABLE PUBLICATION

"Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome"

Authors: Xuguang Zhang, Zhiwei Huang, Xin Wang, Han Hao, Dali Fan, Martin Cadeiras, Yusheng Liu
Journal: Catheterization and Cardiovascular Interventions
Year: 2025

 

Chenliang Ge | Cardio-oncology | Best Research Article Award

Posted on by Cardiology and Cardiovascular Medicine

Mr. Chenliang Ge | Cardio-oncology | Best Research Article Award

The First Affiliated Hospital of Guangxi Medical University | China

Author Profile:

Scopus

Orcid

🫀DR. CHENLIANG GE, MD, PHD – A PIONEERING CARDIOVASCULAR RESEARCHER & CLINICIAN

Dr. Chenliang Ge is an accomplished physician-scientist whose work bridges clinical cardiology and data-driven medical research. With a robust foundation in both molecular mechanisms and large-scale epidemiological analysis, he continues to redefine the frontiers of cardiovascular science and patient care.

🎓 EARLY ACADEMIC PURSUITS

Dr. Ge began his academic journey with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Nanhua University, Hengyang (2008–2013). His passion for cardiology led him to pursue a Master of Science in Cardiology (2013–2016) from the same university. Advancing his specialization, he earned a PhD in Cardiology from Guangxi Medical University, Nanning, China (2019–2022), where he laid the groundwork for his breakthrough research in atrial fibrillation and molecular cardiology.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since 2016, Dr. Ge has served as an Attending Physician at the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. In this role, he:

  • Diagnoses and manages complex cardiovascular conditions.

  • Specializes in radiofrequency ablation procedures for atrial fibrillation (AF) and supraventricular tachycardia.

  • Combines clinical acumen with cutting-edge research to enhance patient outcomes.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIO-ONCOLOGY

Dr. Ge’s research interests lie at the confluence of cardiology, artificial intelligence, and epidemiology. His contributions span three major domains:

1. EPIDEMIOLOGICAL INSIGHTS INTO CVD AND SYSTEMIC HEALTH

  • Cardiovascular Disease and Cancer Mortality (2024): Identified heart failure as a standalone risk factor for cancer mortality using NHANES data.

  • Physical Activity in Hypertension (2024): Demonstrated the life-extending benefits of moderate-intensity exercise in hypertensive patients.

2. MOLECULAR MECHANISMS IN ARRHYTHMIAS

  • PhD Dissertation: Uncovered the role of TLR4 and NLRP3 inflammasome activation in atrial fibrillation.

  • Key Finding (2022): TLR4 silencing reduced atrial fibrosis and AF susceptibility by downregulating NLRP3-TGF-β pathways, suggesting promising therapeutic targets.

3. TECHNOLOGY-DRIVEN DIAGNOSIS AND PROGNOSIS

  • Echocardiographic Risk Stratification (2024): Developed an automated tool using echocardiography to predict left atrial low-voltage areas (LA-LVAs).

  • Gene Signature for NIDCM Prognosis (2020): Created a two-gene model to predict survival and ventricular arrhythmias in non-ischemic dilated cardiomyopathy (NIDCM).

🧠 TECHNICAL AND CLINICAL EXPERTISE

RESEARCH SKILLS:

  • Molecular biology techniques: PCR, Western blotting, immunohistochemistry.

  • Confocal microscopy and in vivo/in vitro models.

  • Epidemiological analysis using NHANES and UK Biobank datasets.

  • Data analytics: Python, R, SPSS; Machine learning and deep learning.

CLINICAL EXPERTISE:

  • Cardiac electrophysiology and ablation procedures.

  • Echocardiography with tools like Philips Epic 7C and AutoStrain.

  • Risk modeling and survival analysis for personalized cardiac care.

🌍 IMPACT AND INFLUENCE

Dr. Ge's work directly informs both clinical practice and public health policy. By connecting chronic diseases like heart failure and cancer, his findings push for integrated healthcare models. His gene-based and imaging-based diagnostic tools enable precision medicine, allowing for personalized and cost-effective interventions.

📚 ACADEMIC CITES

  • Ge et al., 2020 – Gene Signature in NIDCM

  • Ge et al., 2022 – TLR4 & NLRP3 in Atrial Fibrillation

  • Ge et al., 2024 – Physical Activity in Hypertension & CVD-Cancer Link

  • Chang et al., 2024 – Echocardiographic Risk Stratification (collaborative work)

🚀 LEGACY AND FUTURE CONTRIBUTIONS

With a unique blend of clinical insight and computational proficiency, Dr. Ge is at the forefront of next-generation cardiovascular care. His future directions likely include:

  • Expanding the use of AI in cardiology diagnostics.

  • Further investigating multi-system interactions in chronic diseases.

  • Advocating for preventive cardiology through large-scale data and public health outreach.

His legacy is one of bridging bench-to-bedside translation, ensuring that rigorous research translates into better lives for patients globally.

📑 NOTABLE PUBLICATIONS

"The global burden of high BMI among adolescents between 1990 and 2021" 

Authors: Ge C; Xiong J; Zhu R; Hong Z; Yan He
Journal: Communications medicine
Year: 2025

"Automatic Echocardiographic Assessment of Left Atrial Function for Prediction of Low-Voltage Areas in Non-Valvular Atrial Fibrillation" 

Authors: Shuai Chang; Xiaofeng Zhang; Chenliang Ge; Yanfen Zhong; Decai Zeng; Yongzhi Cai; Tongtong
Journal: International Journal of General Medicine
Year: 2024

"Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data" 

Authors: Ge C; Jiang Z; Long B; Lu Q; He Y
Journal: BMC public health
Year: 2024